Outsourced Pharma White Papers

  1. Insights And Effective Strategies For A Successful Technology Transfer 11/1/2024

    Discover key strategies for seamless pharmaceutical technology transfers that accelerate time to market, ensure product quality, and meet regulatory standards across the drug lifecycle.

  2. Developing Pulmonary Dosage Forms For Complex Molecule Delivery 9/23/2025

    Discover how next-generation inhalation technologies can transform pulmonary drug delivery and unlock new therapeutic possibilities for a wide range of respiratory diseases.

  3. Vial Fogging: Practical Considerations For Vial Selection 10/16/2024

    Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.

  4. CHO Cell Lines For Recombinant Protein Production 6/2/2025

    Discover how new strategies in CHO cell line development are driving innovation and transforming the future of biologics manufacturing, from enhanced productivity to improved therapeutic quality.

  5. Reducing Costs & Risks: A Pharma Guide To FTZ Subzones For U.S. Drug Manufacturing 2/11/2025

    Utilized wisely, FTZs and subzones can be tools for cost savings and can enable pharma companies to leverage the benefits of American manufacturing.

  6. Bioconjugates – An Increasing Diversity, A Blossoming Of Therapeutic Applications 10/24/2024

    Harness the power of bioconjugation to revolutionize targeted therapies, enhance drug efficacy, and reduce side effects, paving the way for more precise and effective treatments across a range of diseases.

  7. Streamline Your AAV Process With A Production Platform 10/6/2025

    AAVs are reshaping gene therapy, but scaling production introduces complexity. Learn how upstream process optimization can improve yield, consistency, and speed to meet growing demands.

  8. Single-Use Innovation For The Future Of Therapeutic Manufacturing 1/28/2025

    Gain insight into these end-to-end plasmid DNA solutions, leveraging robust cGMP-compliant processes and single-use manufacturing platforms to accelerate your cell and gene therapy programs.

  9. RNA Nanoparticle: Formulation, Process, And Characterization 10/22/2024

    As the field grows, understanding how to formulate RNA nanoparticles effectively is essential for advancing therapeutic innovations.

  10. Overcoming Challenges In AAV And LV Viral Vector Manufacturing 12/5/2023

    Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production.